Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations.
- Authors
- Lowe, Patrick P; Morel, Caroline; Ambade, Aditya; Iracheta-Vellve, Arvin; Kwiatkowski, Erica; Satishchandran, Abhishek; Furi, Istvan; Cho, Yeonhee; Gyongyosi, Benedek; Catalano, Donna; Lefebvre, Eric; Fischer, Laurent; Seyedkazemi, Star; Schafer, Dorothy P; Szabo, Gyongyi
- Year
- 2020
- Journal
- Journal of neuroinflammation
- PMID
- 33036616
- DOI
- 10.1186/s12974-020-01972-5
- PMCID
- PMC7547498
BACKGROUND: Chronic alcohol consumption is associated with neuroinflammation, neuronal damage, and behavioral alterations including addiction. Alcohol-induced neuroinflammation is characterized by increased expression of proinflammatory cytokines (including TNFΞ±, IL-1Ξ², and CCL2) and microglial activation. We hypothesized chronic alcohol consumption results in peripheral immune cell infiltration to the CNS. Since chemotaxis through the CCL2-CCR2 signaling axis is critical for macrophage recruitment peripherally and centrally, we further hypothesized that blockade of CCL2 signaling using the dual CCR2/5 inhibitor cenicriviroc (CVC) would prevent alcohol-induced CNS infiltration of peripheral macrophages and alter the neuroinflammatory state in the brain after chronic alcohol consumption. METHODS: C57BL/6J female mice were fed an isocaloric or 5% (v/v) ethanol Lieber DeCarli diet for 6 weeks. Some mice received daily injections of CVC. Microglia and infiltrating macrophages were characterized and quantified by flow cytometry and visualized using CX3CR1 CCR2 reporter mice. The effect of ethanol and CVC treatment on the expression of inflammatory genes was evaluated in various regions of the brain, using a Nanostring nCounter inflammation panel. Microglia activation was analyzed by immunofluorescence. CVC-treated and untreated mice were presented with the two-bottle choice test. RESULTS: Chronic alcohol consumption induced microglia activation and peripheral macrophage infiltration in the CNS, particularly in the hippocampus. Treatment with CVC abrogated ethanol-induced recruitment of peripheral macrophages and partially reversed microglia activation. Furthermore, the expression of proinflammatory markers was upregulated by chronic alcohol consumption in various regions of the brain, including the cortex, hippocampus, and cerebellum. Inhibition of CCR2/5 decreased alcohol-mediated expression of inflammatory markers. Finally, microglia function was impaired by chronic alcohol consumption and restored by CVC treatment. CVC treatment did not change the ethanol consumption or preference of mice in the two-bottle choice test. CONCLUSIONS: Together, our data establish that chronic alcohol consumption promotes the recruitment of peripheral macrophages into the CNS and microglia alterations through the CCR2/5 axis. Therefore, further exploration of the CCR2/5 axis as a modulator of neuroinflammation may offer a potential therapeutic approach for the treatment of alcohol-associated neuroinflammation.
Alcohol induces infiltration of peripheral macrophages into the CNS. a Alcohol-fed mice received 5% (v/v) alcohol in Lieber-DeCarli liquid diet ad libitum (EtOH) for 6 weeks while pair-fed animals received a calorie-matched liquid diet (PF). b mRNA expression of Ccl2, Ccr2, and Ccr5 was measured from the hippocampus of PF and EtOH mice. c Brain immune cells from wild-type mice fed chronic alcohol (EtOH) or a pair-fed (PF) control diet were isolated and quantified by flow cytometry gating for live, single cells. Microglia (CD11b+ CD45lo) were differentiated from peripheral macrophages (CD11b+ CD45hi) based on surface marker staining and infiltrating macrophages in pair- vs alcohol-fed mice. d Quantification of microglia (CD11b+ CD45lo) and peripheral macrophages (CD11b+ CD45hi) in PF and EtOH mice. Data are mean Β± SEM, n = 4β7 mice/group. *p < 0.05 by Studentβs t test
Alcohol-induced peripheral macrophages differentially infiltrate the CNS. a CX3CR1eGFP/+ CCR2RFP/+ mice were generated by crossing CX3CR1eGFP/eGFP CCR2+/+ and CX3CR1+/+ CCR2RFP/RFP mice to allow visualization of resident microglia (GFP+; green) and brain infiltrating macrophages (RFP+; red) in the cortex, cerebellum, and hippocampus of mice fed chronic alcohol or a calorie-matched diet. b Acquired Γ 10 images of ethanol-fed CX3CR1eGFP/+ CCR2RFP/+ mice were stitched together to provide the larger representative images shown. c, d Quantification of resident CX3CR1-eGFP+ microglia and CCR2-RFP+ brain infiltrating macrophages in the cortex, cerebellum, and hippocampus. Data are mean Β± SEM, n = 4β7 mice/group. *p < 0.05; n.s., not significant by Studentβs t test
Inhibition of CCR2/5 signaling reduces CNS macrophage infiltration without altering activation marker expression of infiltrating macrophages. a Mice received a pair-fed diet (PF) or chronic alcohol (EtOH), and some alcohol-fed mice received 6 weeks of daily preventive subcutaneous CVC injection (EtOH + 6wk CVC) or 3 weeks of daily CVC treatment (EtOH + 3wk CVC). PF and EtOH mice received daily vehicle control injections. b Representative flow cytometry plots of peripheral macrophages (CD11b+ CD45hi) in EtOH, EtOH + 6wk CVC and EtOH + 3wk CVC-treated mice. c Quantification of infiltrating brain macrophages (CD11b+ CD45hi) in pair-fed, alcohol-fed, and treatment groups. d Expression of various activation markers were measured by flow cytometry in CD11b+ CD45hi infiltrating macrophages including CD86, CD68, MHC-II, CD163, and CD206. Data are mean Β± SEM, n = 6β7 mice/group. *p < 0.05 by one-way ANOVA
Chronic alcohol induces inflammatory gene expression changes in multiple brain regions. a Proinflammatory cytokine proteins TNFΞ±, IL-1Ξ², and IL-6 were measured from the hippocampus of pair- (PF) and alcohol-fed (EtOH) as well as alcohol-fed mice treated with CVC for 3 weeks (EtOH +3wk CVC) by ELISA. b Inflammatory gene expression of pair- and alcohol-fed mice was analyzed using the Nanostring nCounter Immunology Panel and revealed 17 genes significantly altered in the cerebellum (green, expression increased; red, expression decreased). c Gene expression changes of genes found by Nanostring to be altered as well as some common inflammatory markers, and CCR2/5 axis genes were measured in the hippocampus, cortex, and cerebellum by qPCR in a larger cohort of pair- and alcohol-fed mice as well as mice treated with 3 or 6 weeks CVC (purple, > 3-fold increase in expression; cyan > 3-fold decrease in the expression compared to PF; complete gene expression profile data found in Tables 3, 4, and 5). Data are mean Β± SEM, n = 4β6 mice/group. *p < 0.05 by one-way ANOVA
Alcohol-induced morphologic changes in microglia are partially restored by CCR2/5 inhibition. a Representative images of hippocampal microglia (CX3CR1-GFP+; green) displaying altered morphologies in pair-fed (PF) vs alcohol-fed (EtOH) mice, acquired at Γ 63 magnification. b Quantification of average hippocampal microglia soma area (pixel2) and c perimeter distance (pixel length) in mice fed control or alcohol diet or alcohol-fed mice treated with CCR2/5 inhibitor. d Expression of various activation markers were measured by flow cytometry in CD11b+ CD45lo microglia including CD86, CD68, MHC-II, CD163, and CD206. Data are mean Β± SEM, n = 3 mice/group and 3β10 sections/mouse for aβc and n = 6β7 mice/group for d. *p < 0.05 by one-way ANOVA.
Alcohol downregulates the microglial expression of CD68. a Representative images of the hippocampal sections stained for Iba1 (green), CD68 (red), and DAPI (blue) from pair-fed (PF), alcohol-fed (EtOH), and CVC-treated alcohol-fed mice, acquired at Γ 63 magnification. b Quantification of Iba1 and CD68 colocalization, normalized to total Iba1+ area per image in the hippocampal CA1, CA3, and DG regions and throughout the HPF. c Flow cytometry data showing the percent of microglia (defined as CD11b+ CD45lo) that are positive for CD68 expression. Data are mean Β± SEM, n = 3β4 mice/group with 4β5 images per region per mouse. *p < 0.05; n.s., not significant by one-way ANOVA
| Name | Type |
|---|---|
| 2βΞΞCt method local | drug |
| 3wk CVC treatment local | cohort |
| 6wk CVC treatment local | cohort |
| adult mice | cohort |
| AIF1 | gene |
| alcohol | phenotype |
| alcohol abuse | phenotype |
| alcohol-fed mice local | cohort |
| Alcohol-fed mice local | cohort |
| Alcoholβfed mice local | cohort |
| Alcohol-Fed Mice local | cohort |
| Alcohol-Fed Mice + 3wk CVC local | cohort |
| Alcohol-Fed Mice + 6wk CVC local | cohort |
| alcoholic liver disease | phenotype |
| alcohol preference | phenotype |
| Alcohol Use Disorder | phenotype |
| anti-mouse CD16/CD32 mAb local | drug |
| Anti-Rb-488 local | drug |
| Anti-Rt-647 local | drug |
| APC | drug |
| APC/Cy7 local | drug |
| BD Biosciences Cytofix Cytoperm Plus local | drug |
| BD Biosciences LSR II instrument local | drug |
| BioRad CFX96 Real Time System local | drug |
| Blood-brain barrier breakdown local | phenotype |
| brain | anatomy |
| Brain infiltrating macrophages local | phenotype |
| brain tissue | anatomy |
| BSA | drug |
| C1qa | gene |
| C1qb | gene |
| C57BL/6J | cohort |
| CA1 | anatomy |
| CA3 | anatomy |
| Calorie-matched liquid diet local | drug |
| CASP1 | gene |
| Ccl11 local | gene |
| CCL11 local | gene |
| Ccl2 | gene |
| Ccl21 local | gene |
| CCL21 local | gene |
| CCL2 knockout mice local | cohort |
| Ccl3 local | gene |
| CCL3 local | gene |
| CCL5 | gene |
| Ccr2 | gene |
| CCR2/5 inhibitor local | drug |
| CCR2/5 signaling local | phenotype |
| CCR2/5 signaling pathway local | phenotype |
| CCR2-knockout mice local | cohort |
| CCR2+ macrophages local | phenotype |
| CCR2+ peripheral macrophages local | phenotype |
| CCR2RFP homozygous CX3CR1 wildtype mice local | cohort |
| CCR2RFP/RFP mice local | cohort |
| Ccr5 | gene |
| CCR5-knockout mice local | cohort |
| CD11b local | drug |
| CD11b | gene |
| CD11b+CD45hi IMs local | phenotype |
| CD11b+CD45hi macrophages local | phenotype |
| CD163 local | drug |
| CD163 | gene |
| CD206 | drug |
| CD206 local | gene |
| CD45 local | drug |
| CD45 | gene |
| CD68 local | drug |
| CD68 | gene |
| CD68 local | phenotype |
| CD86 local | drug |
| CD86 | gene |
| Cenicriviroc local | drug |
| central nervous system | anatomy |
| cerebellum | anatomy |
| chronic alcohol-fed mice local | cohort |
| chronic alcoholism | phenotype |
| CNS | anatomy |
| CNS macrophage infiltration local | phenotype |
| cortex | anatomy |
| Cox2 local | gene |
| COX2 local | gene |
| CVC local | drug |
| CVC alcohol-fed mice local | cohort |
| CVC-treated alcohol-fed mice local | cohort |
| CVCβtreated alcoholβfed mice local | cohort |
| CVC-treated mice local | cohort |
| Cx3cr1 | gene |
| CX3CR1eGFP/CCR2RFP mice local | cohort |
| CX3CR1eGFP/eGFP mice local | cohort |
| CX3CR1eGFP homozygous CCR2 wildtype mice local | cohort |
| CX3CR1eGFP/wt CCR2RFP/wt mice local | cohort |
| Cytokine expression local | phenotype |
| cytokine protein expression local | phenotype |
| cytokines | drug |
| daily liquid diet consumption local | phenotype |
| Daxx | gene |
| dentate gyrus | anatomy |
| DG | anatomy |
| DNase I | drug |
| Drinking water local | drug |
| ethanol consumption | phenotype |
| Ethanol-fed mice | cohort |
| ethanol preference | phenotype |
| EtOH local | cohort |
| EtOH | drug |
| EtOH + 3wk CVC local | cohort |
| EtOH + 6wk CVC local | cohort |
| FITC | drug |
| FlowJo v10.1 software local | drug |
| frontal cortex | anatomy |
| GAPDH | gene |
| Gnas | gene |
| Goat IgG local | drug |
| Hippocampal atrophy | phenotype |
| Hippocampal volume | anatomy |
| hippocampus | anatomy |
| Hmgn1 local | gene |
| HMGN1 local | gene |
| Hspb1 local | gene |
| HSPB1 local | gene |
| human brain | anatomy |
| humans | cohort |
| hydroxypropyl-Ξ²-cyclodextrin local | drug |
| Iba1 | gene |
| Il17 local | gene |
| IL17 local | gene |
| IL1B | gene |
| IL-1Ξ² | drug |
| Il23 local | gene |
| IL23 local | gene |
| IL-6 | drug |
| IL6 | gene |
| immune infiltration local | phenotype |
| IMs local | phenotype |
| Increased soma size | phenotype |
| inflammation | phenotype |
| ITGB2 | gene |
| Kolliphor HS15 local | drug |
| Lieber-DeCarli liquid diet local | drug |
| lipopolysaccharide (LPS) | drug |
| Live/Dead Fixable Blue Dead Cell Stain Kit local | drug |
| liver fibrosis local | phenotype |
| LPS | drug |
| LSM 700 scanning confocal microscope local | drug |
| LysM local | gene |
| macrophage chemotaxis to liver local | phenotype |
| macrophage infiltration | phenotype |
| macrophages | anatomy |
| Map3k9 | gene |
| Mapk1 | gene |
| Mapk11 local | gene |
| MAPK11 local | gene |
| MEF2A | gene |
| Meninges | anatomy |
| MHC-II local | drug |
| MHC-II local | gene |
| MHC-II local | phenotype |
| mice | cohort |
| microglia | phenotype |
| microglial activation | phenotype |
| Microglial morphologic changes local | phenotype |
| Microglia morphological changes local | phenotype |
| miRNeasy kit | drug |
| monocyte chemoattraction local | phenotype |
| monocytes | cohort |
| motor cortex | anatomy |
| mouse brain | anatomy |
| Mouse nCounter Inflammation Panel local | drug |
| Myd88 | gene |
| Nanodrop 2000 local | drug |
| Nanostring reactions local | drug |
| NCT03028740 local | cohort |
| neurodegeneration | phenotype |
| neuroinflammation | phenotype |
| neurotoxicity | phenotype |
| NLRP3 | gene |
| Non-alcoholic fatty liver disease | phenotype |
| normal goat serum | drug |
| OCT Compound local | drug |
| pair-fed control mice local | cohort |
| pair-fed mice local | cohort |
| Pair-fed mice local | cohort |
| Pairβfed mice local | cohort |
| Pair-Fed Mice local | cohort |
| paraformaldehyde | drug |
| Partial microglia activation local | phenotype |
| PBS/heparin local | drug |
| PEC local | drug |
| PE/Cy7 local | drug |
| Percoll Plus | drug |
| PerCP/Cy5.5 local | drug |
| PF local | cohort |
| Plcb1 | gene |
| prevention cohort local | cohort |
| primary antibody | drug |
| Proinflammatory local | phenotype |
| proinflammatory cytokine production local | phenotype |
| pro-inflammatory cytokines | phenotype |
| Proinflammatory gene expression local | phenotype |
| Prolong Gold Antifade Reagent local | drug |
| Qdot 525 local | drug |
| reactive oxygen species | drug |
| Reduced microglial process length local | phenotype |
| Resident microglia local | phenotype |
| RNA | drug |
| RNA later local | drug |
| rodents | cohort |
| rRNA | drug |
| Secondary antibodies local | drug |
| somatosensory cortex | anatomy |
| sucrose | drug |
| Superficial tissue local | anatomy |
| SYBR Green polymerase local | drug |
| synapse dysregulation local | phenotype |
| synapse structure function local | phenotype |
| synaptic pruning | phenotype |
| TGFB1 | gene |
| TgfΞ²1 | gene |
| Tlr4 | gene |
| TNF | gene |
| TNFA local | gene |
| TNFΞ± | drug |
| total brain volume | anatomy |
| treatment cohort local | cohort |
| Triton X-100 | drug |
| Vehicle control injections local | drug |
| vehicle-treated mice local | cohort |
| water | drug |
| water intake | phenotype |
| wild-type mice | cohort |
| Ym1 | gene |
| Zeiss Observer.Z1 confocal microscope local | drug |
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. | 2025 | 41083468 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cerebellar microglia: On the edge between neuroinflammation and neuroregulation. | Dukhinova MS et al. | β | 2026 | β |
| Diosgenin prevents alcohol-induced intensification of seizures, psychiatric comorbidities, and their neuropathological consequences in kindled epileptic mice. | Ben-Azu B et al. | β | 2026 | β |
| Ethanol induces neuroimmune dysregulation and soluble TREM2 generation in a human iPSC neuron, astrocyte, microglia triculture model. | Boreland AJ et al. | β | 2026 | β |
| Kakkalide promotes spinal cord injury repair by regulating microglial M2 polarization via mitophagy. | You T et al. | β | 2026 | β |
| Naltrexone treatment improves anxiety- and depression-like behavior in alcohol-exposed mice. | Yang S et al. | β | 2026 | β |
| Neuroimmune pathways as targets for precision treatment in alcohol use disorder: A commentary on biomarkers for craving. | Nunez Severino L et al. | β | 2026 | β |
| The effects of alcohol dependence on the CSF proteome in mice: Evidence for blood-brain barrier dysfunction and neuroinflammation. | Turner NP et al. | β | 2026 | β |
| Adolescent Alcohol and the Spectrum of Cognitive Dysfunction in Aging. | Deak T et al. | β | 2025 | β |
| Alcohol, aging, and the gut microbiome: Intersections of immunity, barrier dysfunction, and disease. | Melamed E et al. | β | 2025 | β |
| Alcohol-Induced Oxidative Stress and Gut-Liver-Brain Crosstalk: Expanding the Paradigm from ALD to MetALD. | Lee JY et al. | β | 2025 | β |
| A multifactorial lens on risk factors promoting the progression of Alzheimer's disease. | Parker J et al. | β | 2025 | β |
| Association between dietary fat intake and long-term risk of dementia: a prospective cohort study. | Wu M et al. | β | 2025 | β |
| Binge ethanol consumption can be attenuated by systemic administration of minocycline and is associated with enhanced neuroinflammation in the central amygdala. | Schrank S et al. | β | 2025 | β |
| Chronic alcohol consumption induces phenotypic and functional alterations consistent with a hyper-inflammatory state in peripheral blood mononuclear cell-derived microglia in a rhesus macaque model. | Hemati H et al. | β | 2025 | β |
| Effect of an astrocyte calcium exporter on orbitofrontal cortex neuron excitability, astrocyte-synaptic interaction, and alcohol consumption. | Kastner-Blasczyk AR et al. | β | 2025 | β |
| Effect of chronic alcohol feeding using the Lieber-DeCarli diet on Alzheimer's disease pathology in Tg2576 mice. | Chandrashekar DV et al. | β | 2025 | β |
| Ethanol consumption aggravates amyloid pathology and neuroinflammation in Alzheimer's disease associated with inflammasome activation and ASC speck propagation. | Brezani V et al. | β | 2025 | β |
| Impact of adolescent ethanol binge on serotonin signaling and pain sensitivity post-withdrawal. | Feller AJ et al. | β | 2025 | β |
| Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. | Green NC et al. | β | 2025 | β |
| Neurotoxicity of Chronic Alcohol Exposure: Mechanistic Insights, Cellular Disruption, and Emerging Therapeutic Strategies. | GoΕaszewski P et al. | β | 2025 | β |
| Nitrate ameliorates alcohol-induced cognitive impairment via oral microbiota. | Li X et al. | β | 2025 | β |
| Peripheral inflammation and PSD-95 levels are associated with structural brain changes in individuals with nicotine dependence using e-cigarettes. | Fang Y et al. | β | 2025 | β |
| Pharmacological Depletion of Microglia Protects Against Alcohol-Induced Corticolimbic Neurodegeneration During Intoxication in Male Rats. | Carlson ER et al. | β | 2025 | β |
| Physiological Mechanisms Vulnerable to Alcohol-Induced Alterations: Role in Chronic Comorbidities. | Simon L et al. | β | 2025 | β |
| Pre-Reproductive Excessive Alcohol and Maternal Immune Activation Differentially Affect Offspring Behavior, Neurobiology, and Brain Volume in a Sex-Dependent Manner. | Ott A et al. | β | 2025 | β |
| Proinflammatory Risk Factors in Patients with Ischemic Stroke: A Systematic Review and Meta-Analysis. | Gerdanovics A et al. | β | 2025 | β |
| Purinergic and extracellular vesicle signaling in alcohol-induced blood-brain barrier breakdown and neuroimmune activation. | Togre NS et al. | β | 2025 | β |
| Role of glial cells in neurotoxicological effects of alcohol. | Tizabi Y et al. | β | 2025 | β |
| Sex differences in the microglial response to stress and chronic alcohol exposure in mice. | Soares AR et al. | β | 2025 | β |
| Single-cell transcriptomics of neuroinflammation and cerebrovascular endothelial cells in the aged rat hippocampus. | Liu F et al. | β | 2025 | β |
| Sirtuin 7 Promotes Alcohol-Associated Liver Injury via Modulating Myeloid Cell Chemokine (C-C Motif) Ligand 2 Secretion through the NF-ΞΊB Signaling Pathway. | Wang Z et al. | β | 2025 | β |
| Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer's disease research. | Singhaarachchi PH et al. | β | 2024 | β |
| Alcohol and Periodontal Disease: A Narrative Review. | Gandhi UH et al. | β | 2024 | β |
| Alcohol-Induced Activation of Chemokine System and Neuroinflammation Development. | Mikhalitskaya EV et al. | β | 2024 | β |
| An overview of current advances in perinatal alcohol exposure and pathogenesis of fetal alcohol spectrum disorders. | Zeng X et al. | β | 2024 | β |
| Binge ethanol exposure in advanced age elevates neuroinflammation and early indicators of neurodegeneration and cognitive impairment in female mice. | Anton PE et al. | β | 2024 | β |
| Early-Stage Moderate Alcohol Feeding Dysregulates Insulin-Related Metabolic Hormone Expression in the Brain: Potential Links to Neurodegeneration Including Alzheimer's Disease. | Yang Y et al. | β | 2024 | β |
| Emerging pharmacological targets for alcohol use disorder. | Brockway DF et al. | β | 2024 | β |
| Epigenetic associations of <i>GPNMB</i> rs199347 variant with alcohol consumption in Parkinson's disease. | Chen YC et al. | β | 2024 | β |
| IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study. | Ho MF et al. | β | 2024 | β |
| Inflammation, oxidative stress and gut microbiome perturbation: A narrative review of mechanisms and treatment of the alcohol hangover. | Turner BRH et al. | β | 2024 | β |
| JAK1/2 Regulates Synergy Between Interferon Gamma and Lipopolysaccharides in Microglia. | Young AP et al. | β | 2024 | β |
| Microglia in neuroimmunopharmacology and drug addiction. | Li H et al. | β | 2024 | β |
| Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) Protects against Binge Alcohol-Mediated Gut and Brain Injury. | Ray B et al. | β | 2024 | β |
| Neuroimmune Activation and Microglia Reactivity in Female Rats Following Alcohol Dependence. | Melbourne JK et al. | β | 2024 | β |
| Neuroinflammatory responses and blood-brain barrier injury in chronic alcohol exposure: role of purinergic P2βΓβ7 Receptor signaling. | Togre NS et al. | β | 2024 | β |
| PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury. | Wagner J et al. | β | 2024 | β |
| Pharmacological depletion of microglia protects against alcohol-induced corticolimbic neurodegeneration during intoxication in male rats | Carlson ER et al. | β | 2024 | β |
| Plasma cathepsin D as an early indicator of alcohol-related liver disease. | Li M et al. | β | 2024 | β |
| Protein Kinase C (PKC) in Neurological Health: Implications for Alzheimer's Disease and Chronic Alcohol Consumption. | Singh N et al. | β | 2024 | β |
| Transcriptome changes in the nucleus of the solitary tract induced by repeated stress, alcohol dependence, or stress-induced drinking in dependent mice. | Grantham EK et al. | β | 2024 | β |
| Aggressive-like behaviour and neurocognitive impairment in alcohol herbal mixture-fed mice are associated with increased neuroinflammation and neuronal apoptosis in the prefrontal cortex. | Ajayi AM et al. | β | 2023 | β |
| Alcohol as a Modifiable Risk Factor for Alzheimer's Disease-Evidence from Experimental Studies. | Chandrashekar DV et al. | β | 2023 | β |
| Animal model for high consumption and preference of ethanol and its interplay with high sugar and butter diet, behavior, and neuroimmune system. | Moreira-JΓΊnior RE et al. | β | 2023 | β |
| Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis. | Wei H et al. | β | 2023 | β |
| Characterization of cerebrovascular changes in mice treated with alcohol by photoacoustic imaging. | Sun W et al. | β | 2023 | β |
| Dynamic regulation of the extracellular matrix in reward memory processes: a question of time. | Valeri J et al. | β | 2023 | β |
| Hemolytic iron regulation in traumatic brain injury and alcohol use. | Agas A et al. | β | 2023 | β |
| Methyl vinyl ketone impairs spatial memory and activates hippocampal glial cells in mice. | Sato RY et al. | β | 2023 | β |
| Sex-specific differences in alcohol-induced pain sensitization. | Alexander SN et al. | β | 2023 | β |
| Thirty Risk Factors for Alzheimer's Disease Unified by a Common Neuroimmune-Neuroinflammation Mechanism. | Weaver DF | β | 2023 | β |
| Infiltration of peripheral immune cells into the olfactory bulb in a mouse model of acute nasal inflammation. | Asano H et al. | β | 2022 | β |
| Innate immune activation: Parallels in alcohol use disorder and Alzheimer's disease. | Ramos A et al. | β | 2022 | β |
| Innate immune tolerance against adolescent intermittent alcohol exposure-induced behavioral abnormalities in adult mice. | Ye M et al. | β | 2022 | β |
| NADPH oxidase-induced activation of transforming growth factor-beta-1 causes neuropathy by suppressing antioxidant signaling pathways in alcohol use disorder. | Bhowmick S et al. | β | 2022 | β |
| Neurokinin-1 receptor antagonist rolapitant suppresses anxiety and alcohol intake produced by repeated withdrawal episodes. | Kokhan VS et al. | β | 2022 | β |
| Plasma TNFSF10 levels associated with acamprosate treatment response in patients with alcohol use disorder. | Ho MF et al. | β | 2022 | β |
| Sex differences in stress-induced alcohol intake: a review of preclinical studies focused on amygdala and inflammatory pathways. | Mineur YS et al. | β | 2022 | β |
| Sodium Butyrate Supplementation Modulates Neuroinflammatory Response Aggravated by Antibiotic Treatment in a Mouse Model of Binge-like Ethanol Drinking. | Gao L et al. | β | 2022 | β |
| The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target. | Sophocleous RA et al. | β | 2022 | β |
| Caffeine consumption attenuates ethanol-induced inflammation through the regulation of adenosinergic receptors in the UChB rats cerebellum. | Rossetto IMU et al. | β | 2021 | β |
| Optimized preparation of gastric acid-response sulfhydryl functionalized chitosan/alginate/tilapia peptide hydrogel and its protective effects on alcohol-induced liver and brain injury. | Lu S et al. | β | 2021 | β |